{
  "id": "609949d53a1a4901",
  "title": "Vanda Pharmaceuticals Announces FDA Approval of NEREUS\u2122 ( tradipitant ) for the Prevention of Vomiting Induced by Motion : A Historic Scientific Milestone in the Prevention of Motion Sickness",
  "description": "20251230T234500Z",
  "content": "",
  "source": "prnewswire.com",
  "source_url": "https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-fda-approval-of-nereus-tradipitant-for-the-prevention-of-vomiting-induced-by-motion-a-historic-scientific-milestone-in-the-prevention-of-motion-sickness-302650965.html",
  "published_at": "20251230T234500Z",
  "fetched_at": "2025-12-31T00:23:34.453563+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-fda-approval-of-nereus-tradipitant-for-the-prevention-of-vomiting-induced-by-motion-a-historic-scientific-milestone-in-the-prevention-of-motion-sickness-302650965.html",
    "url_mobile": "",
    "title": "Vanda Pharmaceuticals Announces FDA Approval of NEREUS\u2122 ( tradipitant ) for the Prevention of Vomiting Induced by Motion : A Historic Scientific Milestone in the Prevention of Motion Sickness",
    "seendate": "20251230T234500Z",
    "socialimage": "",
    "domain": "prnewswire.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}